13F-HR filed by Krensavage Asset Management, LLC
Krensavage Asset Management, LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 16 holding rows worth $320,818,000.
- Accession
- 0001609251-18-000002
- Filer
- CIK 1609251
- Filed
- 2018-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 16 entries on the cover page, a total value of $320,818,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $320,818,000 with VALUE read as thousands by filing date, 13F file number 028-16807. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 866,770 | $50,862,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 294,429 | $43,561,000 | thousands by filing date | |
| BIOVERATIV INC | 97075E100 | COM | 730,260 | $39,376,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 478,053 | $34,248,000 | thousands by filing date | |
| SUCAMPO PHARMACEUTICALS-CL A | 864909106 | CL A | 1,304,376 | $23,414,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 126,482 | $19,725,000 | thousands by filing date | |
| INVACARE CORP | 461203101 | COMMON STOCK | 1,107,770 | $18,666,000 | thousands by filing date | |
| HALYARD HEALTH INC | 40650V100 | COM | 395,015 | $18,242,000 | thousands by filing date | |
| RTI BIOLOGICS INC | 74975N105 | COM | 4,334,852 | $17,773,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 324,357 | $17,742,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 87,477 | $15,212,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 159,466 | $8,973,000 | thousands by filing date | |
| CONMED CORP COM | 207410101 | Stock | 164,547 | $8,387,000 | thousands by filing date | |
| JUNIPER PHARMACEUTICALS INC COM | 48203L107 | Stock | 440,102 | $2,134,000 | thousands by filing date | |
| AVIRAGEN THERAPEUTICS INC | 053761102 | COM | 2,809,531 | $1,591,000 | thousands by filing date | |
| DIGIRAD CORP | 253827109 | COM | 354,179 | $912,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001609251-18-000002 | this filing | 2018-02-14 | acceptance time not in the bulk data set |